Protein serine kinase H2 (PSKH2) is a serine/threonine protein kinase that belongs to a larger family of kinases with diverse roles in cellular signaling. As an enzyme, PSKH2 catalyzes the transfer of a phosphate group from ATP to specific serine or threonine residues on target proteins. This post-translational modification can alter the activity, interactions, or localization of these proteins, thereby modulating various cellular processes.Although the full spectrum of PSKH2's biological functions is not completely understood, its kinase activity suggests it could play a role in regulating the cell cycle, DNA repair, apoptosis, and possibly other signaling pathways that are critical for cell proliferation and survival. Kinases like PSKH2 are often part of larger signaling cascades, where they can act as on/off switches for different signaling pathways in response to extracellular or intracellular stimuli.
The substrate specificity of PSKH2, as well as its particular interaction partners and regulatory mechanisms, are areas of ongoing research. Understanding these aspects is crucial for elucidating its function in physiological contexts, as well as in pathological conditions. Kinases often have multiple substrates and can be involved in cross-talk between signaling pathways, which adds complexity to their study.PSKH2's expression patterns, activity regulation by phosphorylation or other post-translational modifications, and its participation in protein complexes are all factors that could provide insight into its role in health and disease. As with many kinases, dysregulation of PSKH2's activity has the potential to contribute to disease states, including cancer, making it a potential target for intervention.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine, a broad-spectrum kinase inhibitor, could indirectly affect PSKH2 by altering the balance of kinase activity in the cell. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
As a protein kinase C inhibitor, Bisindolylmaleimide I might indirectly influence PSKH2 by modulating PKC-dependent signaling pathways. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein, a tyrosine kinase inhibitor, could indirectly affect PSKH2 activity by altering pathways that involve tyrosine phosphorylation. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin increases cAMP levels, potentially influencing PSKH2 indirectly if it's involved in cAMP-dependent signaling pathways. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002, a PI3K inhibitor, might affect PSKH2 activity indirectly by impacting PI3K/Akt signaling pathways. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126, an inhibitor of MEK1/2, could indirectly influence PSKH2 activity by affecting the ERK/MAPK signaling pathway. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin, an mTOR inhibitor, may alter various cellular pathways, potentially influencing PSKH2 activity if it's involved in pathways regulated by mTOR. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059, an MEK inhibitor, might indirectly influence PSKH2 activity by affecting the ERK/MAPK signaling pathway. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580, a p38 MAPK inhibitor, could indirectly affect PSKH2 activity by modulating MAPK-mediated signaling pathways. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin, a PI3K inhibitor, could indirectly affect PSKH2 by altering PI3K/Akt signaling pathways. | ||||||